New Market Research Report: DS Pharma Biomedical Co., Ltd. - Product Pipeline Analysis, 2013 Update
DS Pharma Biomedical Co., Ltd. (DS Pharma) is molecular diagnostic company. The company develops, imports, sells and markets in-vitro diagnostics and research materials. It develops point-of-care tests (POCT) for the detection of influenza and acute myocardial infarction and the measurement kits of bone and calcium metabolic markers to hospitals, physicians and clinical laboratories. DS Pharma also develops and supplies culture media, cell lines, reagents, sera and devices to the pathology and life science research institutions such as universities and the...
View full press release